Melvin Toh serves as the Vice President & Chief Scientific Officer at CK Life Sciences, guiding technology and product development. With over 25 years of experience in Asia and the US, including a prior role as a Director at Pfizer, he specializes in pharmaceuticals and oncology. He earned his MBBS from the National University of Singapore.
He is leading CK Life Sciences development of a novel AI-empowered cancer vaccine platform, aiming to accelerate research and improve the discovery of new therapies.
Read the full overview →They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.